Company profile ATNF
After 39 days of this quarter the interest is at 106.0. Based on that we can calculate that during remaining 52 days it will total up to 247.0. 180 Life Sciences expected interest is significantly higher compared to previous quarter (+2370.0%) and same quarter last year (+1076.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 23 | 19 -17.4% QoQ | 28 47.4% QoQ | 0 -100.0% QoQ |
| 2020 | 26 13.0% YoY inf% QoQ | 23 21.1% YoY -11.5% QoQ | 0 -100.0% YoY -100.0% QoQ | 76 inf% YoY inf% QoQ |
| 2021 | 94 261.5% YoY 23.7% QoQ | 99 330.4% YoY 5.3% QoQ | 12 inf% YoY -87.9% QoQ | 48 -36.8% YoY 300.0% QoQ |
| 2022 | 38 -59.6% YoY -20.8% QoQ | 20 -79.8% YoY -47.4% QoQ | 23 91.7% YoY 15.0% QoQ | 28 -41.7% YoY 21.7% QoQ |
| 2023 | 21 -44.7% YoY -25.0% QoQ | 51 155.0% YoY 142.9% QoQ | 40 73.9% YoY -21.6% QoQ | 10 -64.3% YoY -75.0% QoQ |
| 2024 | 106 404.8% YoY 960.0% QoQ | - | - | - |
The average 5 years interest of 180 Life Sciences was 3.01 per week. The last year interest of 180 Life Sciences compared to the last 5 years has changed by 39.2%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 142.2%.
There is not enough data for Chronic pain therapeutics to provide analysis
There is not enough data for Chronic pain therapeutics to provide correlation calculation
There is not enough data for Chronic pain therapeutics to provide analysis
After 34 days of this quarter the interest is at 155.0. Based on that we can calculate that during remaining 58 days it will total up to 419.0. Inflammation treatment options expected interest is significantly higher compared to previous quarter (+132.8%) and same quarter last year (+498.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 25 |
| 2019 | 49 96.0% QoQ | 132 169.4% QoQ | 152 15.2% QoQ | 85 240.0% YoY -44.1% QoQ |
| 2020 | 88 79.6% YoY 3.5% QoQ | 51 -61.4% YoY -42.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 32 inf% YoY inf% QoQ | 38 inf% YoY 18.8% QoQ | 111 inf% YoY 192.1% QoQ | 70 inf% YoY -36.9% QoQ |
| 2023 | 109 240.6% YoY 55.7% QoQ | 164 331.6% YoY 50.5% QoQ | 180 62.2% YoY 9.8% QoQ | 155 121.4% YoY -13.9% QoQ |
The average 5 years interest of Inflammation treatment options was 5.52 per week. The last year interest of Inflammation treatment options compared to the last 5 years has changed by 136.23%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 89.53%.
There is not enough data for Fibrosis breakthrough to provide analysis
There is not enough data for Fibrosis breakthrough to provide correlation calculation
There is not enough data for Fibrosis breakthrough to provide analysis
There is not enough data for Anti-TNF therapies to provide analysis
There is not enough data for Anti-TNF therapies to provide correlation calculation
There is not enough data for Anti-TNF therapies to provide analysis
There is not enough data for Synthetic Cannabidiol (CBD) to provide analysis
There is not enough data for Synthetic Cannabidiol (CBD) to provide correlation calculation
There is not enough data for Synthetic Cannabidiol (CBD) to provide analysis
There is not enough data for a7nAChR platform to provide analysis
There is not enough data for a7nAChR platform to provide correlation calculation
There is not enough data for a7nAChR platform to provide analysis
There is not enough data for 180 Life Sciences clinical trials to provide analysis
There is not enough data for 180 Life Sciences clinical trials to provide correlation calculation
There is not enough data for 180 Life Sciences clinical trials to provide analysis
There is not enough data for 180 Life Sciences stock price to provide analysis
There is not enough data for 180 Life Sciences stock price to provide correlation calculation
There is not enough data for 180 Life Sciences stock price to provide analysis
There is not enough data for 180 Life Sciences contact information to provide analysis
There is not enough data for 180 Life Sciences contact information to provide correlation calculation
There is not enough data for 180 Life Sciences contact information to provide analysis